A Tribute to Robert A. Fox

1929 - 2021

Learn More

Recent Press Releases

View all ›

Low-dose Administration of MERS DNA Vaccine Candidate Induces Potent Immunity and Protects From Virus Challenge in Preclinical Models

RNA Editing Protein ADAR1 Protects Telomeres and Supports Proliferation in Cancer Cells
 

Wistar Scientists Discover New Mechanism Through Which Senescent Cells Turn On Genes That Encode for Secreted Tumor-regulating Factors 

Our Centers

Maureen and lab

Cancer Center

Wistar is a National Cancer Institute Cancer Center in basic research and has held this designation since 1972.
David and Ami_In the Lab1

Vaccine & Immunotherapy Center

Improving health around the globe by creating and advancing vaccines and immunotherapies.

Upcoming events

View all events ›

Scientific Seminar

Virtual Distinguished Lectures in Cancer Research Series: Altered Protein Glycosylation in Cancer and Roles in Oncogenesis

Scientific Seminar

Virtual Distinguished Lectures in Cancer Research Series: Metabolism, Cellular Decisions and the Language that Unites Them

Symposium

The Noreen O'Neill Melanoma Research Virtual Symposium: Understanding Melanoma Progression and Therapy Resistance

125 Years of Discovery and Counting

View full timeline ›
Kazuko Nishikura, Ph.D.

RNA Editing

Kazuko Nishikura, Ph.D., discovered a mechanism of RNA regulation through which cells can make discrete changes in the sequence of nucleotides — the “letters” in the RNA code, ultimately affecting the protein product. She characterized a family of enzymes called ADAR (adenosine deaminase acting on RNA) that are responsible for RNA editing.

View Full Timeline

Accelerating the future

Right now, Wistar Science is making discoveries that will advance human health.

Support Today